Literature DB >> 15197053

Over-the-counter pain reliever and aspirin use within a sample of long-term cyclooxygenase 2 users.

Emily R Cox1, Mark Frisse, Andrew Behm, Kathleen A Fairman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197053     DOI: 10.1001/archinte.164.11.1243

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  5 in total

1.  Endoscopic ulcer rates in healthy subjects associated with use of aspirin (81 mg q.d.) alone or coadministered with celecoxib or naproxen: a randomized, 1-week trial.

Authors:  Jay L Goldstein; James Aisenberg; Salam F Zakko; Manuela F Berger; William E Dodge
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

Review 2.  Unmet needs in non-steroidal anti-inflammatory drug-induced upper gastrointestinal diseases.

Authors:  James M Scheiman
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance.

Authors:  Jeffrey S Borer; Lee S Simon
Journal:  Arthritis Res Ther       Date:  2005-09-15       Impact factor: 5.156

4.  Telithromycin use and spontaneous reports of hepatotoxicity.

Authors:  David D Dore; Julia R DiBello; Kate L Lapane
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Celecoxib in arthritis: relative risk management profile and implications for patients.

Authors:  Gayle McKellar; Gurkirpal Singh
Journal:  Ther Clin Risk Manag       Date:  2009-11-18       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.